Form D — Averna Therapeutics Inc.
0000911420-25-000115 · filed 2025-04-21
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $85,000,000
- Total sold
- $43,769,227
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Averna Therapeutics Inc.
- CIK
- 2020048
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 134 COOLIDGE AVENUE
WATERTOWN, MA 02472 - Phone
- 972 73 2822600
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Roy Amariglio · DirectorWatertown, MA Find on LinkedIn ↗
-
Stephen Squinto · DirectorWatertown, MA Find on LinkedIn ↗
-
Anat Nursella · Executive OfficerWatertown, MA Find on LinkedIn ↗
-
Tal Zaks, M.D., Ph.D. · DirectorWatertown, MA Find on LinkedIn ↗
-
Aaron Nelson · DirectorWatertown, MA Find on LinkedIn ↗
-
Henry Chen · DirectorWatertown, MA Find on LinkedIn ↗
-
Dylan Morris · DirectorWatertown, MA Find on LinkedIn ↗
-
Raju Prasad, Ph.D. · DirectorWatertown, MA Find on LinkedIn ↗
-
Thomas Barnes, Ph.D. · DirectorWatertown, MA Find on LinkedIn ↗
View original on SEC EDGAR.